Procedural Sedation Withdrawn Phase 2 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0034835 (Procedural Sedation)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00464451Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEGTreatment